Strides Pharma's Bengaluru facility receives EIR from US FDA
The abbreviated Quality System Inspection Technique (QSIT) drug pre-approval on-site inspection was specifically conducted by the US FDA
Quality / GMP | 18/01/2023 | By Sudeep Soparkar | 787
Celadon Pharma's UK-based facility bags GMP registration by MHRA
Celadon's medicinal cannabis product will be supplied in oil form as an API
Quality / GMP | 17/01/2023 | By Sudeep Soparkar | 927
Lupin gets two observations from US FDA for Somerset facility
The inspection closed with the issuance of a Form-483 with two observations
Quality / GMP | 17/01/2023 | By Sudeep Soparkar | 695
Piramal Pharma's Lexington facility gets six observations from US FDA
The observations were classified under VAI (Voluntary Action Indicated) and do not relate to data integrity<br />
Quality / GMP | 17/01/2023 | By Sudeep Soparkar | 521
US FDA issues warning letter to Sun Pharma's Halol unit
Among other violations, the pharma major failed to thoroughly investigate any discrepancy or failure of a batch and failed to clean, maintain, sanitise, sterilise equipment and utensils at appropriate intervals
Quality / GMP | 17/01/2023 | By Sudeep Soparkar | 1020
Lupin, Exeltis bag reimbursement approval for NaMuscla in Spain
NaMuscla is Europe's first and only licensed product for this indication, and it will be commercialised in Spain by Lupin's partner Exeltis
Quality / GMP | 11/01/2023 | By Sudeep Soparkar | 905
Lupin receives US FDA approval for Fesoterodine Fumarate extended-release tabs
The product will be manufactured at Lupin’s facility in Goa
Quality / GMP | 09/01/2023 | By Sudeep Soparkar | 806
Gland Pharma's Dundigal facility gets EIR from US FDA
The US drug regulator inspected the facility from August 22 to August 25, 2022
Quality / GMP | 04/01/2023 | By Sudeep Soparkar | 911
Marion Biotech's facility inspected by drug regulators over Uzbekistan deaths
Uzbekistan said that India-based Marion Biotech's cough syrup resulted in the deaths of 18 children in the country
Quality / GMP | 29/12/2022 | By Sudeep Soparkar | 1003
Alembic Pharma bags US FDA approval for Fulvestrant injection single-dose prefilled syringe
Fulvestrant Injection is an estrogen receptor antagonist indicated for the treatment of breast cancer
Quality / GMP | 26/12/2022 | By Sudeep Soparkar | 871
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy